Our latest articles
Keeping community pharmacy informed since 1886
Changes to the Australian asthma guidelines: how pharmacists can adapt
National Asthma Council’s Debbie Rigby with PDL professional officer and QLD director describe the changes to asthma management guidelines, and discuss how pharmacists can assist patients 15 July 2025 | …
Research Roundup
Debbie Rigby rounds up the latest in research news Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype In the MATINEE trial, treatment with mepolizumab, a humanized monoclonal antibody …
Optimising anticoagulants for older persons with atrial fibrillation
Optimising therapy for the increasing population of older adults with atrial fibrillation (AF) is challenging. AF is associated with a 5-fold risk of stroke and systemic embolism.1 To mitigate these risks, …
Bipolar and related disorders
Pharmacists play an important role in managing bipolar disorder by providing medication-related information, educating patients and their families, and collaborating with healthcare providers to optimise treatment plans. They can improve …
Medicinal cannabis: the pharmacist’s role in supporting its rational and safe use by patients
For pharmacists to best support the safe and rational use of medicinal cannabis products, they must be equipped with the relevant knowledge not only about the clinical role of medicinal …
Oesophageal spasms: an overview
Pharmacists can play a significant role in supporting patients with oesophageal spasms through medicine counselling, lifestyle modification advice, and recognising patients that require further medical assessment by a GP or …
Complementary and alternative medicines for weight reduction
The complementary and alternative medicine (CAM) sector of the weight loss market often receives poor press because of the lack of scientific evidence underpinning products. Pharmacists can be implicated in …
Butler open to pharmacy vaping reforms
Efforts to restrict access to nicotine vaping products are delivering positive results, Minister tells pharmacists Measures aimed at driving down vaping among “kids” are achieving their goal, Minister for Health, …
Mounjaro KwikPen transition complete: Lilly
Eli Lilly confirms that Mounjaro (tirzepatide) will no longer be available in vial presentations, after transitioning the product to a multi-dose, pre-filled pen Mounjaro manufacturer, Eli Lilly, has informed the …
APC calls time on CPD standards
Retirement of the Australian Pharmacy Council’s CPD standards will bring the profession into alignment with the broader professional development accreditation landscape The Australian Pharmacy Council (APC) has announced the cessation …
From clean beauty to compounding: setting pharmacy skincare apart
Convenience, product choice and advice are key drivers of pharmacy skincare. But what challenges, opportunities and trends may shape its future? Leanne Philpott investigates In 2024, the Australian skincare market …
The intelligent pharmacy investor
Buying a pharmacy is more than just a financial investment, but buyers must be careful to not let emotion and sentiment override a smart decision, says Natalie Sirianni Sometimes working …